LDV Blog

At LDV Capital's 2026 Annual General Meeting, Principal Ash Cleary outlined how visual technology and AI are driving the next wave of intelligent automation across legacy industries. Moving beyond basic digitization, advances in computer vision, machine perception, robotics, digital twins, and spatial intelligence are enabling autonomous decision-making in logistics, construction, manufacturing, and mining. The article explores trillion-dollar opportunities emerging from these technologies and why visual data is becoming the foundation for the future of industrial infrastructure.

Explore the "Internet of Eyes" (IoEyes) concept: a network of visual sensors and cameras that will give inanimate objects the ability to "see," exponentially impacting businesses and humanity through computer vision and AI. Written by Evan Nisselson, Founder and General Partner at LDV Capital, this article was originally published on The Next Web on May 13, 2016, and is being reposted without changes.

Evan Nisselson, Founder and General Partner at LDV Capital, first met Victor Riparbelli, Co-Founder & CEO at Synthesia, in November 2018 and shared his team’s vision to empower anyone to create video content without cameras or studios. In 2019, LDV Capital led their $3.1M Seed financing.

In January 2025, the company announced their $180 million in a Series D round led by NEA, with participation from WiL, Atlassian Ventures, PSP Growth and existing investors. Adobe Ventures made a strategic investment in April 2025. That same month, the company surpassed $100 million in annual recurring revenue. Synthesia is now the UK’s most valuable generative AI media company and the worldwide market leader in enterprise AI video. Most recently, the team announced Synthesia 3.0, the next era of video.

At our 11th Annual LDV Vision Summit, Evan and Victor discussed Victor’s journey, Synthesia’s rapid growth and the future potential of AI video, including the rise of video agents – the next big shift toward making videos interactive and personalized, evolving the medium beyond a one-way broadcasting format.

Meet Dr. Daniel Sodickson – Chief of Innovation in Radiology at NYU Grossman School of Medicine and an Expert at LDV Capital. In his book, “The Future of Seeing: How Imaging Is Changing Our World”, he traces humanity’s long quest to illuminate the invisible – from the first biological eyes that evolved in Earth’s ancient oceans to the telescopes, microscopes and MRI machines that map worlds beyond the reach of natural vision. Blending history, science and imagination, he reveals how imaging has reshaped medicine, altered economies and reframed our understanding of privacy and identity. Now, on the brink of an AI-driven revolution, Dr. Sodickson invites us to consider a future in which technology emulates not just our sight, but our very minds – changing how we see the world, each other and ourselves. Dan’s vision aligns with our fund’s thesis dating back to 2012.

Evan Nisselson, Founder and General Partner of LDV Capital, explores technological advancements that are transforming bathrooms into triage centers for monitoring health, extending health spans and proactively saving lives.

With new multimodal models emerging almost weekly, staying current on computer vision and machine learning can be challenging. At our 11th Annual LDV Vision Summit, Dr. Serge Belongie – Professor at the University of Copenhagen, Head of the Danish Pioneer Centre for AI, and LDV Capital Expert in Residence – shared key insights behind these advances.

We are very excited to partner with the fantastic deep tech team at ResiQuant that is developing a platform that utilizes agentic AI and computer vision to transform data into actionable, building-level insights. This empowers property owners and carriers to mitigate vulnerabilities, streamline workflows and enhance underwriting decisions.

We at LDV Capital led their $4M seed round with participation from Foothill Ventures, Pear VC, Alumni Ventures and angels.

In September 2021, Ash Cleary began his venture capital journey by joining Evan Nisselson and our LDV Capital team as an Analyst, investing out of Fund III as part of a two-year program. After successfully completing the program, Ash was promoted to Associate and now invests out of LDV Capital's fourth fund.

Check out his insights and reflections on the past three years—working with the team and collaborating with brilliant deep tech entrepreneurs worldwide, building businesses powered by visual technology and artificial intelligence.

We are excited to partner and invest in the brilliant VitVio team. They are building an AI-driven computer vision platform designed to enhance the safety and efficiency of hospital operating theaters.

We at LDV Capital led their $2M pre-seed round with participation from Bek Ventures (ex-Earlybird), Tiny Supercomputer Investment Company, and angel investors.

VitVio has also announced their pilot program with the Royal Orthopaedic Hospital (ROH), one of the UK's three leading medical institutions in orthopedic care and “one of the best hospitals in the world.”

Dr. David Rabuka is a serial biotech entrepreneur and investor based in Berkeley California. His expertise is concentrated on translating new technologies into clinical therapies. In 2024, Dr. Rabuka spoke about investment trends & opportunities in ​​life sciences and biotech at our Annual General Meeting. Check out our shortened & lightly edited transcript.

Meet Dr. Molly Gibson – Co-Founder and Chief Strategy & Innovation Officer at Generate:Biomedicines, Origination Partner at Flagship Pioneering. LDV Capital's Founder & General Partner Evan Nisselson discussed with Molly how AI and machine learning empower and disrupt the scientific process across life sciences, biotech, advanced materials and more.

If you missed our 10th Annual LDV Vision Summit, this is your chance to watch the video or read our shortened & lightly edited transcript.

Matt Uyttendaele is the director of the AI for Chemistry group at Meta. His group applies machine learning to material discovery for several applications: clean hydrogen, sorbents for direct air capture, and next-generation displays. In 2024, we were honored to have him speak at our Annual General Meeting about a new application of AI that he has been working on for the last few years and how it relates to his career in visual technologies.

Our Annual General Meetings (AGM) are exclusive, invite-only events for LDV Capital LPs, portfolio companies, LDV experts and special guests. We are thrilled to share a glimpse of our most recent AGM in New York City, giving you a unique opportunity to see what usually happens behind closed doors.

As the biotech industry heavily relies on data filtering, analysis, and sharing, visual technologies play a critical role in detecting and imaging biological systems. This paves the way for the future of life sciences tools, enabling next-generation therapeutics, biomanufacturing, and longevity. At our 10th Annual LDV Vision Summit earlier this year, a panel of experts delved into these topics and explored various critical aspects shaping the future of biotechnology. Check out their insights.

We at LDV Capital celebrated our 10th LDV Vision Summit Anniversary! People from over 30 countries were part of our premier global gathering in visual tech & AI. We were thrilled to welcome speakers from Sequoia Capital, Wellville, Generate:Biomedicines, DCVC Bio, Princeton University, Stanford University, University of California, Nobias Therapeutics, Snap, Future Ventures, Meta, Axios and more. Two of our LDV Capital portfolio companies presented as well: Synthesia and Sonus Microsystems.

We believe that visual technologies will continue to be the crux of advancements in materials science, across nanomaterials and metamaterials, resulting in the transformation of various industrial, medical and consumer applications. Embedded AI will enable materials to reconfigure themselves autonomously in response to their environment. As sensing abilities and algorithms improve, the full potential of navigating the compositional and configurational possibilities of materials will catalyze widespread transformation for optics, biomarker diagnostics, robotics, 3D printing and more.

On March 21, at our 10th Annual LDV Vision Summit, Evan Nisselson, Founder and General Partner at LDV Capital, will speak with Dr. Molly Gibson – Co-Founder and Chief Strategy and Innovation Officer at Generate:Biomedicines. They will discuss how AI and machine learning empower and disrupt the scientific process across life sciences, biotech, advanced materials, and more. This will have a tremendous impact on business and society.

As we approach our 10th Summit anniversary on March 21, 2024, we decided to go down memory lane and spotlight the exceptional fireside chat speakers LDV Capital's Evan Nisselson has had the privilege to witness and interview over the years. These leaders come from companies such as DeepMind, Sequoia Capital, Union Square Ventures, Meta, Spark Capital, FirstMark, Universal Pictures, Greylock Partners, Snap, First Round Capital, OpenWater and more.